Emergency Department Septic Screening in Respiratory Syncytial Virus (RSV) and Non-RSV Bronchiolitis.
OBJECTIVE
To identify factors associated with culture-proven serious bacterial infection (SBI) and positive emergency department septic screening (EDSS) tests in children with bronchiolitis and to identify factors associated with the performance of EDSS.


METHODS
We reviewed an existing study database of patients with bronchiolitis. We defined a positive EDSS as urine with >/=10 WBC per high power field or cerebrospinal fluid (CSF) with >/=10 WBC per high power field (>25 WBC in neonates), or if organisms were identified on gram stain. We defined SBI as significant growth of an accepted pathogen in blood, urine or CSF. Our composite endpoint was positive if either of these was positive. The decision to perform testing was modeled using modified Poisson regression; the presence of the combined outcome was modeled using logistic regression modified for rare events.


RESULTS
We studied 640 children. Testing was performed in 199/640 (31.1%). These tended to be younger than two months RR 2.69 (95% CI 2.11, 3.44), febrile RR 2.01 (95% CI 1.58, 2.55), more dehydrated RR 1.50 (95% CI 1.28, 1.75) and had more severe chest wall retractions RR 1.54 (95% CI 1.22, 1.94). Only 11/640(1.7%) had a positive EDSS or SBI. Younger age (OR 0.67 per month; 95% CI 0.45, 0.99) and a negative RSV antigen test (OR 6.22; 95% CI 1.30, 29.85) were associated with the composite endpoint.


CONCLUSIONS
Testing was more likely to be performed in children younger than two months of age, and in those who were febrile, dehydrated, and had more severe chest wall retractions. A positive EDSS or SBI was rare occurring in younger infants with non-RSV bronchiolitis.
Chee
Chris
C
Kern Medical Center, Department of Emergency Medicine, Bakersfield, CA.
Walsh
Paul
P
Kuan
Sam
S
Cabangangan
Juanito
J
Azimian
Kian
K
Dong
Christopher
C
Tobias
Joshua
J
Rothenberg
Stephen J
SJ
Pediatr Infect Dis J. 2004 Nov;23(11):995-9
15545853
J Pediatr. 1962 Dec;61:864-9
14010259
Eur J Emerg Med. 2004 Oct;11(5):265-72
15359199
J Med Virol. 2005 Feb;75(2):282-9
15602730
Pediatrics. 2006 May;117(5):e878-86
16618789
J Infect Dis. 2004 Jun 1;189(11):2047-56
15143472
Arch Pediatr Adolesc Med. 1999 Dec;153(12):1310-1
10591315
Acad Emerg Med. 2008 Feb;15(2):111-8
18275439
Pediatrics. 2004 Jun;113(6):1728-34
15173498
Pediatr Infect Dis J. 1998 Mar;17(3):231-6
9535251
J Virol. 2005 Dec;79(23):14992-7
16282501
J Clin Microbiol. 1998 Feb;36(2):421-6
9466752
Pediatrics. 2003 Aug;112(2):282-4
12897274
J Clin Microbiol. 2006 Aug;44(8):2739-42
16891486
Arch Pediatr Adolesc Med. 2002 Oct;156(10):1055-6; author reply 1056-7
12361456
JAMA. 2004 Mar 10;291(10):1203-12
15010441
Pediatr Rev. 1993 Apr;14(4):134-9
8516237
Arch Pediatr Adolesc Med. 2002 Apr;156(4):322-4
11929363
Pediatr Infect Dis J. 2003 Dec;22(12):1053-6
14688564
Acad Emerg Med. 2008 Apr;15(4):305-13
18370982
J Infect Dis. 2007 Apr 15;195(8):1126-36
17357048
Pediatr Emerg Care. 2006 May;22(5):316-20
16714958
Arch Pediatr Adolesc Med. 1997 Dec;151(12):1207-14
9412595
Pediatr Infect Dis J. 1996 Apr;15(4):304-9
8866798
Pediatrics. 2006 Apr;117(4):1094-100
16585303
Pediatrics. 2004 Jun;113(6):1662-6
15173488
Pediatr Infect Dis J. 1999 Mar;18(3):258-61
10093948
Am J Epidemiol. 2004 Apr 1;159(7):702-6
15033648
Medicine (Baltimore). 1969 Jul;48(4):307-32
4897133
Pediatr Infect Dis J. 2000 Mar;19(3):223-7
10749464
Pediatrics. 1982 Apr;69(4):409-12
7070887
Pediatrics. 1998 Jun;101(6):E1
9606243
Arch Pediatr Adolesc Med. 1999 May;153(5):525-30
10323635
Am J Epidemiol. 2004 Apr 1;159(7):683-92
15033646